Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 105006
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105006
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105006
Figure 1 Mesenchymal stromal cells enhances stemness and chemoresistance of gastric cancer cells.
A-E: The MKN45 and AGS cells were co-cultured with mesenchymal stromal cells (MSCs); The stemness was analyzed using sphere formation assay (A); The mRNA expression of SOX2, Oct4, LIN28, and CD133 was measured by qPCR (B); The levels of SOX2, Oct4, LIN28, and CD133 was detected by Western blot analysis (C); The CD44+ and CD133+ cells were identified by flow cytometry analysis (D and E); F and G: The MKN45 and AGS cells were co-cultured with MSCs and treated with oxaliplatin or 5-Fu; The cell apoptosis was determined by flow cytometry analysis (F); The cell proliferation was examined by colony formation assay (G). aP < 0.01; MSC: Mesenchymal stromal cell.
- Citation: Lyu XJ, Zhou L, Jiang XM, Zheng D. Mesenchymal stem cell-derived lncRNAs NKILA contributes to stemness and chemoresistance by fatty acid oxidation in gastric cancer via miR-485-5p/STAT3. World J Gastrointest Oncol 2025; 17(8): 105006
- URL: https://www.wjgnet.com/1948-5204/full/v17/i8/105006.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.105006